Key statistics
As of last trade, Tempus AI Inc (TEM*:MEX) traded at 965.00, 21.16% above the 52 week low of 796.50 set on Apr 21, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 990.00 |
|---|---|
| High | 990.00 |
| Low | 965.00 |
| Bid | 931.71 |
| Offer | 977.89 |
| Previous close | 965.00 |
| Average volume | 115.86 |
|---|---|
| Shares outstanding | 177.91m |
| Free float | 103.89m |
| P/E (TTM) | -- |
| Market cap | 9.94bn USD |
| EPS (TTM) | -1.18 USD |
Data delayed at least 20 minutes, as of Feb 10 2026 11:30 GMT.
More ▼
Press releases
- Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
- Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
- Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
- Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
- Tempus Announces the Launch of Paige Predict
- Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
- Northwestern Medicine Selects Tempus to Expand Genomic Testing
- Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
- Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
- Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium
More ▼
